Eurofins CDMO Alphora Inc., operating as part of the Eurofins CDMO network of companies provides Active Pharmaceutical Ingredient (API) and DP (Drug product) technology development services for the scale-up of complex small molecules with pharmaceutical and biotechnology applications, including high potency compounds. These FDA inspected and approved Contract Development Manufacturing Organization (CDMO) facilities include GMP Kilo Laboratories, GMP Plant operations, Organic and Analytical Laboratories, and supporting Quality Control and Quality Assurance/Compliance functions. A separate suite is used for the handling of highly potent compounds. Most recently a new Solid State Research & Development (SSRD) and Pre-formulation and Formulation Laboratories have come online as part of a new Drug Product Operations suite for a total of 88,500+ ft² across 4 locations operating as a contiguous site. An additional campus-style building is under construction to provide additional support and capacity for an active pipeline of projects.Founded in 2003, Eurofins CDMO Alphora Inc. has established a key management team with over 275 years of combined experience, driving a highly talented team with notable success in developing and successfully implementing API technologies for hundreds of pre-clinical and clinical compounds.more...See more text
Products and Services
Process Development,
DoE and QbD,
Analytical Validation and Development,
Stability Testing,
Gram to Kilogram synthesis,
GMP and non-GMP,
High Potency,
Fast Track services,
Flow Chemistry,
Solid State Research & Development,
Drug Product Operations (Pre-Formulation & Formulation),